Difference between revisions of "Nabilone (Cesamet)"
Jump to navigation
Jump to search
Warner-admin (talk | contribs) m (Text replacement - "Category:Drug index" to "Category:Drugs") |
Warner-admin (talk | contribs) m (Text replacement - "[[Category:Drugs FDA" to "[[Category:FDA") |
||
(One intermediate revision by one other user not shown) | |||
Line 1: | Line 1: | ||
− | =Mechanism of action= | + | ==Mechanism of action== |
Synthetic cannabinoid with antiemetic properties. No known antineoplastic properties. | Synthetic cannabinoid with antiemetic properties. No known antineoplastic properties. | ||
+ | |||
+ | ==Also known as== | ||
+ | *'''Brand name:''' Cesamet | ||
[[Category:Drugs]] | [[Category:Drugs]] | ||
+ | [[Category:Oral medications]] | ||
[[Category:Emesis prevention]] | [[Category:Emesis prevention]] | ||
[[Category:Cannabinoid]] | [[Category:Cannabinoid]] | ||
− | [[Category: | + | [[Category:FDA approved in 1985]] |
Latest revision as of 19:13, 30 July 2018
Mechanism of action
Synthetic cannabinoid with antiemetic properties. No known antineoplastic properties.
Also known as
- Brand name: Cesamet